In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Beta Bionics Inc’s stock clocked out at $19.11, down -0.83% from its previous closing price of $19.27. In other words, the price has decreased by -$0.83 from its previous closing price. On the day, 0.64 million shares were traded.
Ratios:
To gain a deeper understanding of BBNX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.93 and its Current Ratio is at 15.88. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on May 30, 2025, initiated with a Outperform rating and assigned the stock a target price of $20.
On May 30, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $16.
On February 24, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $25.Stifel initiated its Buy rating on February 24, 2025, with a $25 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 02 ’25 when Sean Saint bought 3,439 shares for $17.89 per share.
Hopman Mark sold 868 shares of BBNX for $15,529 on Jun 02 ’25. The Chief Commercial Officer now owns 34,132 shares after completing the transaction at $17.89 per share. On Jun 02 ’25, another insider, Russell Steven Jon, who serves as the Chief Medical Officer of the company, sold 1,039 shares for $17.89 each. As a result, the insider received 18,588 and left with 72,032 shares of the company.
Stock Price History:
Over the past 52 weeks, BBNX has reached a high of $24.50, while it has fallen to a 52-week low of $8.89. The 50-Day Moving Average of the stock is 41.59%, while the 200-Day Moving Average is calculated to be 20.60%.
Shares Statistics:
A total of 43.35M shares are outstanding, with a floating share count of 33.23M. Insiders hold about 23.36% of the company’s shares, while institutions hold 83.50% stake in the company.
